Table 1.
Number of samples in BN/AMA+ individuals and PBC patients according to time stations and respective time intervals
| Time stations | Interval from baseline (years) | Number of individuals in each group | ||
|---|---|---|---|---|
| Minimum | Maximum | BN/AMA+ | PBC | |
| T0 | – | – | 59 (100%) | 35 (100%) |
| T1 | ≥ 0.5 | < 1.5 | 23 (39%) | 9 (26%) |
| T2 | ≥ 1.5 | < 2.5 | 20 (34%) | 12 (34%) |
| T3 | ≥ 2.5 | < 3.5 | 26 (44%) | 14 (40%) |
| T4 | ≥ 3.5 | < 4.5 | 26 (44%) | 17 (49%) |
| T5 | ≥ 4.5 | < 5.5 | 21 (36%) | 14 (40%) |
| T6 | ≥ 5.5 | < 6.5 | 16 (27%) | 17 (49%) |
| T7 | ≥ 6.5 | < 7.5 | 8 (14%) | 10 (29%) |
BN/AMA+ biochemically normal and anti-mitochondria antibody-positive individuals, PBC primary biliary cholangitis